•Association of SGLT2 inhibitors use with a lower risk of biliary diseases in patients with type 2 diabetes mellitus: a retrospective cohort study
•A novel pathogenic variant for dubin-johnson syndrome in a case of hyperbilirubinemia and metabolic associated fatty liver disease
•Prognostic value of functional MRI and liver function synergy in hepatocellular carcinoma patients receiving combined locoregional-systemic therapy: A multicenter scoring model
•The effect of plasma exchange on immune function in patients with hyperbilirubinemia at different severity levels following liver cancer surgery
•Chondroitin Sulfate-Based ROS-Responsive Nanoparticles Targeting Activated Myofibroblasts via CD44 Receptors for the Renal Fibrosis Therapy